Document is current
Any future updates will be listed below
-
Authors
Yu, Kyle L.
Ho, Matthew https://orcid.org/0000-0001-7937-1557
Paruzzo, Luca
Stella, Federico https://orcid.org/0000-0003-3401-1309
Patel, Heta
Hasanali, Zainul S.
Kapur, Shivani
Waxman, Adam J.
Vogl, Dan T. https://orcid.org/0000-0002-2935-2566
Stadtmauer, Edward A.
Fraietta, Joseph A.
Ruella, Marco https://orcid.org/0000-0003-4301-5811
Cohen, Adam D. https://orcid.org/0000-0003-0939-3843
Garfall, Alfred L. https://orcid.org/0000-0003-2791-5748
Susanibar-Adaniya, Sandra https://orcid.org/0000-0003-0703-2518
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (5T32HG009495)
Guerry Career Development Award
Colton Center Pilot Award, the Laffey-McHugh Foundation, and the Berman and Maguire Funds for Lymphoma Research at Penn
Scholar in Clinical Research Award from the Leukemia & Lymphoma Society
- License Information
-
More Information
Article History
Received: 14 August 2025
Revised: 13 October 2025
Accepted: 28 October 2025
First Online: 5 November 2025
Competing interests
: D.T.V. has received research funding from Takeda and Active Biotech and consulting fees from Takeda, Karyopharm, GSK, Genentech, and Sanofi. E.A.S. declares research funding from AbbVie and K36; consultancy for Amgen, BMS, Celgene, and Janssen. M.R. has patents related to CD19 CAR T-cells; consults for GLG, Guidepoint, AbClon, Acera, Vittoria Bio; research funding received from AbClon, Oxford NanoImaging, Vittoria Biotherapeutics, CURIOX, and Beckman Coulter; scientific founder of Vittoria Biotherapeutics. A.D.C. has received research support from Novartis, GSK, Genentech, and Janssen; consulting fees from Janssen, BMS, GSK, Genentech, Legend, Sanofi, Pfizer, AbbVie, Regeneron, Moderna, AstraZeneca, iTeos, Prothena, Kite, Novartis, Ichnos; and has patents related to CAR T cells. A.L.G. declares research support from Johnson & Johnson, Novartis, Tmunity, and CRISPR Therapeutics; consultancies/honoraria from Johnson & Johnson, Novartis, BMS, Regeneron, AbbVie, AstraZeneca, Smart Immune, and Gracell Bio; and DSMB membership for Janssen. S.S.A. discloses research funding from Johnson & Johnson and consulting from Johnson & Johnson and Sanofi. The other authors declare no competing interests.
